| Noubar Kessimian, MD | |
|
111 Brewster St, Department Of Pathology, Pawtucket, RI 02860-4400 | |
| (401) 729-2392 | |
| (401) 729-2990 |
| Full Name | Noubar Kessimian |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 111 Brewster St, Pawtucket, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649255118 | NPI | - | NPPES |
| 7002239 | Medicaid | RI | |
| 007061041 | Other | RI | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD05825 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Noubar Kessimian, MD 111 Brewster St, Wood Bldg #516, Pawtucket, RI 02860-4400 Ph: (401) 729-3481 | Noubar Kessimian, MD 111 Brewster St, Department Of Pathology, Pawtucket, RI 02860-4400 Ph: (401) 729-2392 |
News Archive
Scientists at UT Southwestern Medical Center have found a potential new way to stop the bacteria that cause gastroenteritis, tularemia and severe diarrhea from making people sick.
A new study reports the results of a viral detection study carried out in buses used for public transport across the final week of lockdown, as travel restrictions were being lifted step by step. This study by Italian researchers and published on the preprint server bioRxiv* in June 2020, may help to understand how a virus can spread within a city bus during normal operation and how effective are the measures used to protect against such transmission.
Research suggests that the extent of presynaptic dopaminergic denervation before starting therapy may predict which patients with Parkinson's disease will later develop levodopa-induced dyskinesia.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
› Verified 2 days ago
Yaoxian Ding, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 111 Brewster St, Department Of Phatology, Pawtucket, RI 02860 Phone: 401-729-2393 Fax: 401-729-2990 | |
Stanley Schwartz, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 111 Brewster St, Memorial Hospital Of Ri/ Pathology Department, Pawtucket, RI 02860 Phone: 401-729-2709 Fax: 401-729-3886 |